Researchers tracked data from nearly 8,000 patients evaluated with Heartflow's FDA-cleared Plaque Analysis software. Overall, the technology's Plaque Staging feature was found to provide significant value during the diagnosis and management of these patients.

The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine. 

When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision. 

Consistently incorporating unsalted peanuts into a person’s diet enhances cerebral blood flow to multiple brain regions. 

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview. 

Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep. 

The rise of these medications continues to be one of the biggest stories in healthcare.

In some cases, researchers noted, cardiologists may need to rely on transcaval access during the treatment of a high-risk heart failure patient.